Strategic partnerships Virgo collaborates with top-tier medical centers such as The Cleveland Clinic, Mount Sinai, Mass General, and UChicago, indicating strong validation and potential co-development or pilot opportunities to demonstrate ROI with major health systems.

EndoML platform The launch of EndoML at DDW 2025 positions Virgo as a scalable AI platform for gastroenterology and research, presenting a clear entry point for enterprise sales to hospitals, academic centers, and pharma companies seeking endoscopic AI capabilities.

Large endoscopy dataset With the largest dataset of endoscopy videos, Virgo can offer data-driven insights, analytics services, and custom model training partnerships, appealing to research consortia and device manufacturers aiming to enhance diagnostic accuracy.

Board and leadership Strategic board addition and ongoing emphasis on foundation models signal maturity and governance, creating trust for large institutions and potential investors seeking stability and direction in AI-driven healthcare solutions.

Early-stage revenue potential Current revenue is in the $1M-$10M range with $13M in funding, suggesting readiness for pilot deployments, consulting engagements, and licensing deals with health systems and research institutions looking to expedite AI-enabled endoscopy adoption.